It has been well established that the 'late' anaemia, almost invariably found in a preterm low birthweight infant, is due to iron deficiency (Mackay, 1928) . We have investigated the iron status of preterm low birthweight infants before and during treatment with oral iron, by measuring their Hb concentration, serum iron concentration, and total iron binding capacity. Together these parameters provide essentially the same information regarding iron deficiency as does its evaluation by means of iron staining of bone marrow aspirates (Bainton and Finch, 1964 their mean birthweight was 1517 g (range 920 to 1870 g). The infants were not suffering from any disease and were born to mothers who were not anaemic during pregnancy. All were fed with the same brand of evaporated milk throughout the period of inpatient care. All received 1 mg vitamin K at birth and were prescribed paediatric mixture offerrous sulphate BP, 180 mg/day, from the age of 5 weeks. Iron fortified cereals were introduced in the infants' diet according to commonpractice. In addition, during the first month of life 17 randomly selected infants ofthose to be discussed in this paper received a total of 14 mg vitamin B12 coenzyme and another 10 a total of 1 4 mg pteroylmonoglutamic acid. The administration schedules for pteroylmonoglutamic acid and vitamin B12 coenzyme have been described in detail elsewhere Lord, Simpson, and Burland, 1971) .
The infants were bled on at least three occasions and most of them on six occasions: for the first time within 3 days of birth, then between the 17th and 21st day, during the fifth week of life, and at 3, 6, and 9 months. Venous blood samples were used for all the haematological determinations. The measurements of Hb concentration (cyanmethaemoglobin) was carried out as described by Dacie and Lewis (1968) . In the absence of an 386 Iron status ofpreterm low birthweight infants and their response to oral iron established normal range of Hb concentration for preterm low birthweight infants, a concentration of 11 g/100 ml was taken to represent the lower limit of normal as for term infants (Committee on Nutrition of the American Academy of Pediatrics, 1969) .
Serum iron concentration was measured by the automated micromethod (Garry and Owen, 1967) , and unsaturated iron binding capacity of serum by a semiautomated method (Brozovic and Copestake, 1969) . From these two measurements total iron binding capacity of serum (TIBC) was calculated. Transferrin saturation represents the ratio between serum iron and TIBC expressed in per cent. As there is no generally accepted normal range for serum iron concentration and TIBC for infants, the normal range for serum iron (65 to 160 ptg/100 ml), TIBC (290 to 410 ug/100 ml), and transferrin saturation (20 to 50%) for adults of both sexes was used for comparison. In this study a distinction between iron deficiency and iron deficiency anaemia has been made with respect to Hb concentration, which is normal in the former and reduced in the latter condition (Finch et al., 1968) . It has been assumed that a low serum iron concentration, high TIBC, and low transferrin saturation indicate reduced or absent storage iron.
Results
All the infants were included into a single group because there was no significant difference in Hb concentration, serum iron concentration, and TIBC of serum between the infants treated with pteroylmonoglutamic acid or vitamin B12 coenzyme and those who were untreated.
Hb concentration. There was a rapid fall of total Hb concentration from the mean of 16 8 g/100 ml at birth to the lowest mean of 9 * 7 g/100 ml at the age of one month (Fig. 1) . Thereafter Hb increased to mean values of 10 -1, 11 4, 11 *5 g/100 ml at 3, 6, and 9 months, respectively. Serum iron concentration and iron binding capacity of serum. The mean serum iron concentration increased from 78 ,ug/100 ml at birth to 105 ,ug/100 ml after 2 weeks of life. Thereafter, the mean serum iron concentration fell gradually to its lowest value (44 ,ug/100 ml) at 6 months, and increased only slightly (51 ,ug/100 ml) by 9 months of age.
The mean TIBC was 252 Fg/10O ml at birth and increased only slightly during the first 5 weeks of life. The mean TIBC increased considerably to 492 [g/100 ml at 3 months and reached 537 and 539 [Lg/100 ml at 6 and 9 months of age, respectively.
The relation between serum iron and TIBC in individual infants is presented in Fig. 2 ,ugllOO ml) and total iron binding capacity pg/100 ml) for adults of both sexes. The lines 20% and 50% represent percentage transferrin saturation.
daily. The described changes in preterm low birthweight infants treated with iron are essentially the same as those found in nontreated infants presented in a classical review of the anaemia of prematurity by Schulman (1959) . The pattern of changes of serum iron concentration and TIBC in preterm low birthweight infants treated with iron is reported for the first time and it is similar to that found in term infants receiving iron-fortified diets (Smith and Hunter, 1970) .
The results presented here suggest that iron absorption in preterm low birthweight infants receiving supplementation is not sufficient to provide the amount of iron required for erythropoiesis. At present the reason is unknown, but the following two observations from published reports provide a basis for speculation.
It has been reported that in adult patients with iron deficiency anaemia there is a two-to fourfold decrease in iron absorption one month after the initiation of treatment with iron, and even before Hb rises to the normal range (Norrby and Solvell, 1970) .
It is possible that a similar reduction in iron absorption occurs in infants receiving iron supplements. Secondly, Halvorsen and Halvorsen (1973) found that in young rabbits the rate of iron release from plenteous iron stores was too slow to prevent the development of anaemia by the time they were 3 weeks old. If the mechanism of iron release from the tissues which store iron is at fault, then perhaps the release of iron from the intestinal mucosal cell may also be impaired. One or both of these two mechanisms may be responsible, at least in part, for an inadequate uptake of iron by the mucosal intestinal cell and/or its subsequent release to the circulation in preterm low birthweight infants treated with oral iron.
In conclusion, the provision of therapeutic doses of oral iron in preterm low birthweight infants does not prevent the development of iron deficiency and even iron deficiency anaemia. Further investigation into the absorption of iron by preterm low birthweight infants on oral iron supplements seems to be desirable. 
